fMRI study on effect of NK1 antagonist (Aprepitant) on cognitive function in normal subjects

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2010
INTERVENTION: 1day 1 time Aprepitant 125mg washout duration 1 week 1day 1 time placebo (lactose) 1day 1 time placebo (lactose) washout duration 1 week 1day 1 time Aprepitant 125mg CONDITION: Substance‐related disorders, Mood disorders, Anxiety disorders PRIMARY OUTCOME: Comparison between placebo and Aprepitant conditions. INCLUSION CRITERIA: healthy adult
Epistemonikos ID: bbaec7a4dae1b4c88f8284ec5dc013df1dfe644c
First added on: Aug 22, 2024